278 related articles for article (PubMed ID: 22766894)
1. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia.
Okten A; Cakir M; Makuloglu M
Minerva Endocrinol; 2012 Sep; 37(3):275-82. PubMed ID: 22766894
[TBL] [Abstract][Full Text] [Related]
2. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
Girgis R; Winter JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
[TBL] [Abstract][Full Text] [Related]
3. Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults.
Barnes MS; Robson PJ; Bonham MP; Strain JJ; Wallace JM
Eur J Clin Nutr; 2006 Jun; 60(6):727-33. PubMed ID: 16391584
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D levels in post-menopausal Korean women with a distal radius fracture.
Jang WY; Chung MS; Baek GH; Song CH; Cho HE; Gong HS
Injury; 2012 Feb; 43(2):237-41. PubMed ID: 22088327
[TBL] [Abstract][Full Text] [Related]
6. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
Sciannamblo M; Russo G; Cuccato D; Chiumello G; Mora S
J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248
[TBL] [Abstract][Full Text] [Related]
7. Bone metabolism in cholestatic children before and after living-related liver transplantation--a long-term prospective study.
Kryskiewicz E; Pawlowska J; Pludowski P; Ismail H; Karczmarewicz E; Teisseyre M; Skorupa E; Ryzko J; Kalicinski P; Socha J; Lorenc RS
J Clin Densitom; 2012; 15(2):233-40. PubMed ID: 22154432
[TBL] [Abstract][Full Text] [Related]
8. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
Falhammar H; Filipsson Nyström H; Wedell A; Brismar K; Thorén M
Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
[TBL] [Abstract][Full Text] [Related]
10. Serum markers of bone turnover in children and adolescents with classic galactosemia.
Gajewska J; Ambroszkiewicz J; Radomyska B; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Milanowski A
Adv Med Sci; 2008; 53(2):214-20. PubMed ID: 18650146
[TBL] [Abstract][Full Text] [Related]
11. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
12. Eating restraint is negatively associated with biomarkers of bone turnover but not measurements of bone mineral density in young women.
Nickols-Richardson SM; Beiseigel JM; Gwazdauskas FC
J Am Diet Assoc; 2006 Jul; 106(7):1095-101. PubMed ID: 16815126
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
Hitz MF; Jensen JE; Eskildsen PC
Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
[TBL] [Abstract][Full Text] [Related]
14. Calciotropic hormones and bone markers in the elderly.
Gallagher JC; Kinyamu HK; Fowler SE; Dawson-Hughes B; Dalsky GP; Sherman SS
J Bone Miner Res; 1998 Mar; 13(3):475-82. PubMed ID: 9525348
[TBL] [Abstract][Full Text] [Related]
15. [Estimation of influence of congenital-adrenal hyperplasia treatment on bone mineralisation evaluated with densitometry].
Romanowska H; Krzywińska-Zdeb E; Giżewska M; Kotkowiak L; Safranow K; Horodnicka-Józwa A; Petriczko E; Krupa B; Walczak M
Pediatr Endocrinol Diabetes Metab; 2012; 18(1):21-6. PubMed ID: 22525687
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
Ooms ME; Lips P; Roos JC; van der Vijgh WJ; Popp-Snijders C; Bezemer PD; Bouter LM
J Bone Miner Res; 1995 Aug; 10(8):1177-84. PubMed ID: 8585420
[TBL] [Abstract][Full Text] [Related]
17. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
Koetz KR; Ventz M; Diederich S; Quinkler M
J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover.
Schou AJ; Heuck C; Wolthers OD
Acta Paediatr; 2003 Jul; 92(7):797-801. PubMed ID: 12892157
[TBL] [Abstract][Full Text] [Related]
20. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
